Paul Mattison

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

John Zajicek, Jeremy Hobart, Anita Slade et al. · Journal of Neurology Neurosurgery & Psychiatry · 2012 · 260 citations · Full text

Reliability and clinical significance of mobility and balance assessments in multiple sclerosis

Yvonne C. Learmonth, Lorna Paul, Angus McFadyen et al. · International Journal of Rehabilitation Research · 2012 · 138 citations

The effects of a 12-week leisure centre-based, group exercise intervention for people moderately affected with multiple sclerosis: a randomized controlled pilot study

Lorna Paul, Linda Miller, Paul Mattison et al. · Clinical Rehabilitation · 2011 · 123 citations

Web-based physiotherapy for people moderately affected with Multiple Sclerosis; quantitative and qualitative data from a randomized, controlled pilot study

Lorna Paul, Elaine Coulter, Linda Miller et al. · Clinical Rehabilitation · 2014 · 92 citations